Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Desrayaud

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 31, 2004
GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependentDavid A Slattery, Sandrine Desrayaud, John F Cryan
Journal of Neurochemistry|January 31, 2006
The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivoTina Gjoni, Sandrine Desrayaud, Stefan Imobersteg, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|September 23, 2022
A practical approach to the optimization of positron emission tomography imaging agents for the central nervous systemYves P Auberson, Akané Lièvre, Sandrine Desrayaud, et al.
International Journal of Peptide Research and Therapeutics|March 13, 2018
Modulation of Oral Bioavailability and Metabolism for Closely Related Cyclic HexapeptidesThomas Vorherr, Ian Lewis, Joerg Berghausen, et al.
Molecular Pharmaceutics|November 6, 2024
DeepCt: Predicting Pharmacokinetic Concentration-Time Curves and Compartmental Models from Chemical Structure Using Deep LearningMaximilian Beckers, Dimitar Yonchev, Sandrine Desrayaud, et al.
Chemmedchem|May 1, 2015
MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod)Emmanuelle Briard, Bettina Rudolph, Sandrine Desrayaud, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK ProfileDavid Carcache, Ivo Vranesic, Joachim Blanz, et al.
Chemmedchem|July 19, 2025
Estimation of In Vivo Half-Life From In Vitro Metabolic Clearance, Protein, and Cell Membrane Affinity AssaysCarla Pou Miralbell, Sandrine Desrayaud, Berndt Oberhauser, et al.
Chemmedchem|April 18, 2024
Developing Low Molecular Weight PET and SPECT Imaging AgentsLian Xue, Caitlin V M L Jie, Sandrine Desrayaud, et al.
Chemmedchem|April 21, 2016
Pharmacokinetic Studies around the Mono- and Difunctionalization of a Bioavailable Cyclic Decapeptide ScaffoldMarianne Fouché, Michael Schäfer, Markus Blatter, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|August 31, 2004
GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependentDavid A Slattery, Sandrine Desrayaud, John F Cryan
Journal of Neurochemistry|January 31, 2006
The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivoTina Gjoni, Sandrine Desrayaud, Stefan Imobersteg, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|September 23, 2022
A practical approach to the optimization of positron emission tomography imaging agents for the central nervous systemYves P Auberson, Akané Lièvre, Sandrine Desrayaud, et al.
International Journal of Peptide Research and Therapeutics|March 13, 2018
Modulation of Oral Bioavailability and Metabolism for Closely Related Cyclic HexapeptidesThomas Vorherr, Ian Lewis, Joerg Berghausen, et al.
Molecular Pharmaceutics|November 6, 2024
DeepCt: Predicting Pharmacokinetic Concentration-Time Curves and Compartmental Models from Chemical Structure Using Deep LearningMaximilian Beckers, Dimitar Yonchev, Sandrine Desrayaud, et al.
Chemmedchem|May 1, 2015
MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod)Emmanuelle Briard, Bettina Rudolph, Sandrine Desrayaud, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK ProfileDavid Carcache, Ivo Vranesic, Joachim Blanz, et al.
Chemmedchem|July 19, 2025
Estimation of In Vivo Half-Life From In Vitro Metabolic Clearance, Protein, and Cell Membrane Affinity AssaysCarla Pou Miralbell, Sandrine Desrayaud, Berndt Oberhauser, et al.
Chemmedchem|April 18, 2024
Developing Low Molecular Weight PET and SPECT Imaging AgentsLian Xue, Caitlin V M L Jie, Sandrine Desrayaud, et al.
Chemmedchem|April 21, 2016
Pharmacokinetic Studies around the Mono- and Difunctionalization of a Bioavailable Cyclic Decapeptide ScaffoldMarianne Fouché, Michael Schäfer, Markus Blatter, et al.
Pageof 4